(NYSE:PFS), ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) — Provident Bank, a leading New Jersey-based financial institution, announced today the results of its annual Economic Outlook Survey. The findings signal a decisive shift in business sentiment. While business owners remain mindful of inflation and trade tensions, the “wait and see” period of 2025 has ended, […]
15th Jan 2026 10:30 AM – 10:55 AM PST Elizabethan D – Private Company Track; Westin St. Francis Hotel, San Francisco, CA EMERYVILLE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — Totus Medicines, a clinical stage, precision medicines company leveraging AI-powered small molecule drug discovery to advance a differentiated pipeline of therapeutics against high-value, historically difficult
(NASDAQ:SABS),(NASDAQ:SABSW), MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that the Company's CEO Samuel J. Reich will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15 at
Boston, MA, USA, Jan. 06, 2026 (GLOBE NEWSWIRE) — Novidea, the global leader in cloud-native insurance management platforms, has announced that Colmobil, a large distributor of private and commercial vehicles and automotive service provider has chosen Novidea's end-to-end platform to modernise and unify its insurance operations. The deployment will streamline workflows, eliminate manual processes, and
(NASDAQ:XBP), IRVING, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a workflow automation leader that leverages decades of industry experience, a global footprint, and agentic AI to rethink business process automation and digital transformation, today announced it has received written notice from The Nasdaq Stock
WATERTOWN, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) — Seismic Therapeutic, Inc., the machine learning immunology company, today announced an update to its presentation scheduled at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California. Jo Viney, Ph.D., Founder, President and Chief Executive Officer, will now present a company overview on Monday, January 12,
NESS ZIONA, Israel and WASHINGTON, Jan. 06, 2026 (GLOBE NEWSWIRE) — Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform antibodies into multifunctional, programmable medicines, today announced the appointment of Roger Waltzman as Chief Medical Officer. Dr. Waltzman, an experienced leader in both drug development and patient care, will
(NASDAQ:MGNI), NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Magnite (MGNI), the largest independent sell-side advertising company, and Cognitiv, the leading advanced performance partner powered by deep learning, today announced a real-time data integration to expand curation capabilities available across ClearLine, Magnite's unified activation and curation solution. This collaboration gives media buyers more effective ways
WATERTOWN, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) — Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced the appointment of Mythili Koneru, MD, PhD, as Chief Medical Officer. Dr. Koneru will lead clinical development, medical strategy, and regulatory engagement as
(NYSE:CXW), BRENTWOOD, Tenn., Jan. 06, 2026 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (“CoreCivic”) announced today that it will release its 2025 fourth quarter financial results after the market closes on Wednesday, February 11, 2026. A live broadcast of CoreCivic's conference call will begin at 10:00 a.m. central time (11:00 a.m. eastern time) on Thursday,